Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.

Using Holter recordings and based on the principle that most of the survivors of acute myocardial infarction who are going to die suddenly after hospital discharge are those who present ventricular premature beats (VPB), the authors have studied the effect of three different antidysrhythmic drugs -...

Full description

Bibliographic Details
Main Authors: J. L. Tuna, M. J. Correia, V. Corrêa d'Almeida, L. Mourão, F. Leal da Costa, C. Ribeiro
Format: Article
Language:English
Published: Ordem dos Médicos 1980-12-01
Series:Acta Médica Portuguesa
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4294
_version_ 1811195849525428224
author J. L. Tuna
M. J. Correia
V. Corrêa d'Almeida
L. Mourão
F. Leal da Costa
C. Ribeiro
author_facet J. L. Tuna
M. J. Correia
V. Corrêa d'Almeida
L. Mourão
F. Leal da Costa
C. Ribeiro
author_sort J. L. Tuna
collection DOAJ
description Using Holter recordings and based on the principle that most of the survivors of acute myocardial infarction who are going to die suddenly after hospital discharge are those who present ventricular premature beats (VPB), the authors have studied the effect of three different antidysrhythmic drugs - procainamide (PA), oxprenolol (OX) and amiodarones. (AMIOD) - in late phase of acute myocardial infarction. All the trials have been controlled Procainamide (47 patients studied), in comparison with placebo (PL), revealed to be effective (a) in supressing and diminishing VPB/hour (p=0.0425), and (b) in maintaining patients with no VPB (PA 89.6% - PL 64.7%). Oxprenolol (27 patients studied), in comparison with placebo, revealed to be effective (a) in maintaining patients with no VPB (p=0.0525), and (b) in avoiding the increase of VPB/hour (p=0.0576). Finally amiodarone (37 patients studied), in comparison with placebo, was effective (a) in maintaining patients with no VPB (AMIOD 50% - PL 39%), (b) in diminishing VPB/hour (AMIOD 29% - PL 9%), and (c) in avoiding the increase of VPB/hour (AMIOD 79% - PL 48%). The authors finish their paper emphasizing that no antidysrhythmic drug should be introduced in clinical practice before being submitted to controlled studies with Holter electrocardiography.
first_indexed 2024-04-12T00:49:22Z
format Article
id doaj.art-8e6531dbeda949d49d6f3d10f3e8aa89
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-12T00:49:22Z
publishDate 1980-12-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-8e6531dbeda949d49d6f3d10f3e8aa892022-12-22T03:54:46ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07581980-12-01210.20344/amp.4294Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.J. L. Tuna0M. J. Correia1V. Corrêa d'Almeida2L. Mourão3F. Leal da Costa4C. RibeiroUTIC. Hospital Santa Maria. Lisboa. PortugalUTIC. Hospital Santa Maria. Lisboa. PortugalUTIC. Hospital Santa Maria. Lisboa. PortugalUTIC. Hospital Santa Maria. Lisboa. PortugalUTIC. Hospital Santa Maria. Lisboa. Portugal Using Holter recordings and based on the principle that most of the survivors of acute myocardial infarction who are going to die suddenly after hospital discharge are those who present ventricular premature beats (VPB), the authors have studied the effect of three different antidysrhythmic drugs - procainamide (PA), oxprenolol (OX) and amiodarones. (AMIOD) - in late phase of acute myocardial infarction. All the trials have been controlled Procainamide (47 patients studied), in comparison with placebo (PL), revealed to be effective (a) in supressing and diminishing VPB/hour (p=0.0425), and (b) in maintaining patients with no VPB (PA 89.6% - PL 64.7%). Oxprenolol (27 patients studied), in comparison with placebo, revealed to be effective (a) in maintaining patients with no VPB (p=0.0525), and (b) in avoiding the increase of VPB/hour (p=0.0576). Finally amiodarone (37 patients studied), in comparison with placebo, was effective (a) in maintaining patients with no VPB (AMIOD 50% - PL 39%), (b) in diminishing VPB/hour (AMIOD 29% - PL 9%), and (c) in avoiding the increase of VPB/hour (AMIOD 79% - PL 48%). The authors finish their paper emphasizing that no antidysrhythmic drug should be introduced in clinical practice before being submitted to controlled studies with Holter electrocardiography. https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4294
spellingShingle J. L. Tuna
M. J. Correia
V. Corrêa d'Almeida
L. Mourão
F. Leal da Costa
C. Ribeiro
Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
Acta Médica Portuguesa
title Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
title_full Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
title_fullStr Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
title_full_unstemmed Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
title_short Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
title_sort procainamide oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4294
work_keys_str_mv AT jltuna procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction
AT mjcorreia procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction
AT vcorreadalmeida procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction
AT lmourao procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction
AT flealdacosta procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction
AT cribeiro procainamideoxprenololandamiodaroneasantidysrhythmicdrugsinmyocardialinfarction